Discussion about this post

User's avatar
ForkInSocket's avatar

You really shouldn't refer to it as "merckmectin". That implies that this new drug is a good alternative, or operates in a similar way. In fact, this new drug does NOT operate in the same way as Ivermectin. It consists of an analog of cytosine, one of the 4 bases of DNA and RNA. The body can't tell it apart from cytosine, so it uses it in DNA/RNA replication, but it's specifically designed to cause replication errors. While this does interfere with replication of an RNA virus, it is non-specific so it will also cause problems in any other mechanisms that would require cytosine. There's no reason to think that this wouldn't cause errors elsewhere that result in a broad spectrum of problems that may not be immediately apparent. Thus no reason to expect it to be safe long-term.

Whereas Ivermectin is not only shown to be effective against SARS2, it also has a 30 year safety record with widespread use, and it is a naturally occurring molecule that is therefore more likely to be generally compatible with human biology.

I know it's just a joke but we must be careful about language here!

Expand full comment
Caresse's avatar

Excellent, as usual.

Expand full comment
16 more comments...

No posts

Ready for more?